Percutaneous Microwave Ablation Yields 76% 10-Year Overall Survival for Renal Cell Carcinoma
Percutaneous MWA of T1 RCC showed 76% 10-year overall survival, 85% cancer-specific survival, and 83% local progression-free survival, with stable renal function and low complications.